AptarGroup (ATR) Scheduled to Post Quarterly Earnings on Thursday

AptarGroup (NYSE:ATR) is scheduled to announce its earnings results after the market closes on Thursday, April 25th. Analysts expect the company to announce earnings of $1.12 per share for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.

AptarGroup (NYSE:ATR) last issued its quarterly earnings data on Friday, February 9th. The industrial products company reported $1.21 earnings per share for the quarter, topping analysts’ consensus estimates of $1.12 by $0.09. AptarGroup had a net margin of 8.16% and a return on equity of 14.46%. The business had revenue of $838.48 million during the quarter, compared to analysts’ expectations of $842.50 million. During the same period in the previous year, the company earned $0.92 earnings per share. AptarGroup’s revenue for the quarter was up 5.3% on a year-over-year basis. On average, analysts expect AptarGroup to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.

AptarGroup Price Performance

Shares of AptarGroup stock opened at $140.17 on Wednesday. AptarGroup has a 1-year low of $111.63 and a 1-year high of $145.35. The firm has a fifty day simple moving average of $140.69 and a 200-day simple moving average of $131.86. The stock has a market capitalization of $9.28 billion, a price-to-earnings ratio of 32.98, a PEG ratio of 3.82 and a beta of 0.59. The company has a current ratio of 1.24, a quick ratio of 0.83 and a debt-to-equity ratio of 0.29.

AptarGroup Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, May 16th. Investors of record on Thursday, April 25th will be given a dividend of $0.41 per share. This represents a $1.64 dividend on an annualized basis and a yield of 1.17%. The ex-dividend date of this dividend is Wednesday, April 24th. AptarGroup’s dividend payout ratio (DPR) is currently 38.59%.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the stock. Wells Fargo & Company boosted their target price on shares of AptarGroup from $157.00 to $160.00 and gave the stock an “overweight” rating in a research report on Thursday, March 7th. Robert W. Baird raised shares of AptarGroup from a “neutral” rating to an “outperform” rating and boosted their target price for the stock from $125.00 to $150.00 in a research report on Wednesday, January 3rd.

Insider Buying and Selling at AptarGroup

In other AptarGroup news, insider Gael Touya sold 3,500 shares of the business’s stock in a transaction on Monday, March 11th. The shares were sold at an average price of $142.84, for a total value of $499,940.00. Following the sale, the insider now owns 33,426 shares of the company’s stock, valued at approximately $4,774,569.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other news, CEO Stephan B. Tanda sold 32,000 shares of the company’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $141.67, for a total value of $4,533,440.00. Following the sale, the chief executive officer now owns 159,024 shares of the company’s stock, valued at approximately $22,528,930.08. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Gael Touya sold 3,500 shares of the company’s stock in a transaction dated Monday, March 11th. The stock was sold at an average price of $142.84, for a total transaction of $499,940.00. Following the completion of the sale, the insider now directly owns 33,426 shares in the company, valued at approximately $4,774,569.84. The disclosure for this sale can be found here. Insiders have sold 37,500 shares of company stock valued at $5,318,280 in the last 90 days. 1.00% of the stock is currently owned by company insiders.

About AptarGroup

AptarGroup, Inc designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments.